# Capecitabine Versus S-1 in Elderly Advanced Gastric Cancer (AGC): Randomized Trial

> **NCT00278863** · PHASE2 · COMPLETED · sponsor: **Asan Medical Center** · enrollment: 96 (actual)

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** S-1
- **DRUG:** Capecitabine

## Key facts

- **NCT ID:** NCT00278863
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11
- **Primary completion:** 2007-01
- **Final completion:** 2007-01
- **Target enrollment:** 96 (ACTUAL)
- **Last updated:** 2014-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00278863

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00278863, "Capecitabine Versus S-1 in Elderly Advanced Gastric Cancer (AGC): Randomized Trial". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT00278863. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*